Dolby Laboratories (NYSE:DLB) Issues FY25 Earnings Guidance

Dolby Laboratories (NYSE:DLBGet Free Report) updated its FY25 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.43-2.58 for the period, compared to the consensus earnings per share estimate of $2.77. The company issued revenue guidance of $1.33-1.39 billion, compared to the consensus revenue estimate of $1.33 billion. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Dolby Laboratories Stock Down 0.6 %

DLB opened at $70.93 on Wednesday. The company has a market capitalization of $6.76 billion, a price-to-earnings ratio of 32.39 and a beta of 0.98. The firm has a 50-day moving average price of $73.69 and a 200-day moving average price of $76.01. Dolby Laboratories has a twelve month low of $66.35 and a twelve month high of $90.06.

Dolby Laboratories announced that its board has initiated a stock repurchase program on Wednesday, August 7th that authorizes the company to buyback $350.00 million in outstanding shares. This buyback authorization authorizes the electronics maker to reacquire up to 5% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board of directors believes its stock is undervalued.

Analysts Set New Price Targets

DLB has been the subject of several recent research reports. StockNews.com upgraded Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Monday. Barrington Research reaffirmed an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a report on Friday, September 20th.

View Our Latest Report on DLB

Insider Buying and Selling

In other news, CEO Kevin J. Yeaman sold 28,512 shares of Dolby Laboratories stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the completion of the sale, the chief executive officer now owns 83,721 shares in the company, valued at approximately $6,205,400.52. This trade represents a 25.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 39.54% of the stock is currently owned by company insiders.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Read More

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.